Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Feldman, J. L.; Fox, J. J.; Martinez, D. F.; Autio, K. A.; Durack, J. C.; Humm, J.; Schoder, H.; Gavane, S. C.; Curtis, K. R.; Balakirsky, S. M.; Cohen, R. M.; Scher, H. I.; Larson, S. M.; Morris, M. J.
Abstract Title: Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613203410
PROVIDER: wos
Notes: Meeting Abstract: 5016 -- Source: Wos
MSK Authors
  1. Josef J Fox
    44 Fox
  2. Michael Morris
    274 Morris
  3. Karen Anne Autio
    42 Autio
  4. Heiko Schoder
    285 Schoder
  5. Somali C Gavane
    12 Gavane
  6. John Laurence Humm
    339 Humm
  7. Steven M Larson
    766 Larson
  8. Howard Scher
    818 Scher
  9. Jeremy Charles Durack
    84 Durack
  10. Kristen   Curtis
    11 Curtis
  11. Jarett Lawrence Feldman
    10 Feldman